enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Vaxart Bags $453M Worth BARDA-Funded Project, Seeks To ... - AOL

    www.aol.com/vaxart-bags-453m-worth-barda...

    The funding from the award will be disbursed in two installments, with an initial sum of about $65.7 million accessible immediately to facilitate ongoing study start-up endeavors.

  3. Biomedical Advanced Research and Development Authority

    en.wikipedia.org/wiki/Biomedical_Advanced...

    The Biomedical Advanced Research and Development Authority (BARDA) is a U.S. Department of Health and Human Services (HHS) office responsible for the procurement and development of medical countermeasures, principally against bioterrorism, including chemical, biological, radiological and nuclear (CBRN) threats, as well as pandemic influenza and emerging diseases.

  4. CSL gets $121 million contract to increase US stockpile for ...

    www.aol.com/news/csl-gets-121-million-contract...

    The funding is part of a partnership with the Biomedical Advanced Research and Development Authority (BARDA). Under the multi-year contract CSL will deliver its MF59 adjuvant, an ingredient that ...

  5. ModeX Therapeutics Secures $35 Million BARDA Supplement to ...

    lite.aol.com/tech/story/0022/20241007/9251021.htm

    Brings total awards from BARDA to $110 million for development of broad SARS-CoV-2 and Influenza multispecifics, with potential funding of up to $205 million if all options are executed; Development work is based on ModeX proprietary MSTAR technology that incorporates multiple antibody binding sites into a single molecule

  6. Opko Health (OPK) Q3 2024 Earnings Call Transcript - AOL

    www.aol.com/opko-health-opk-q3-2024-031510536.html

    So, collectively, this non-dilutive funding brings the total committed support from BARDA actually at $110 million with a potential for a total of $203 million in total if all options and ...

  7. Vaxart - Wikipedia

    en.wikipedia.org/wiki/Vaxart

    Vaxart, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of oral recombinant vaccines administered using temperature-stable tablets that can be stored and shipped without refrigeration, eliminating the need for needle injection.

  8. Alliance for Biosecurity - Wikipedia

    en.wikipedia.org/wiki/Alliance_for_Biosecurity

    Seventy-three percent of the 1,612 Americans polled said they would support a congressional decision to increase funding to address biosecurity needs and capabilities. The poll was conducted, in part, to measure support for biosecurity funding because reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) is due by September ...

  9. Moderna: Phase 3 Trial and Additional BARDA Funding ... - AOL

    www.aol.com/news/moderna-phase-3-trial...

    The new award follows a $483 million grant provided by BARDA in April, which means Moderna has now received a total of $955 million in funding from the U.S. government.The award coincides with the ...